Zhang, Baoshan
Gollapudi, Deepika
Gorman, Jason
O’Dell, Sijy
Damron, Leland F.
McKee, Krisha
Asokan, Mangaiarkarasi
Yang, Eun Sung
Pegu, Amarendra
Lin, Bob C.
Chao, Cara W.
Chen, Xuejun
Gama, Lucio
Ivleva, Vera B.
Law, William H.
Liu, Cuiping
Louder, Mark K.
Schmidt, Stephen D.
Shen, Chen-Hsiang
Shi, Wei
Stein, Judith A.
Seaman, Michael S.
McDermott, Adrian B.
Carlton, Kevin
Mascola, John R.
Kwong, Peter D.
Lei, Q. Paula
Doria-Rose, Nicole A.
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
National Institutes of Health
Article History
Received: 7 April 2022
Accepted: 14 October 2022
First Online: 25 October 2022
Competing interests
: NDR, JG, PDK, and JRM are co-inventors on a patent including the CAP256-VRC26.25 antibody, US application 16/718,322 pending. All other authors report no competing interests.